M. Giewat

An abnormal Ca(2+) response in mutant sarcomere protein-mediated familial hypertrophic cardiomyopathy.

James O. Mudd, J. Seidman, D. Fatkin, 2000, The Journal of clinical investigation.

An abnormal Ca2+ response in mutant sarcomere protein–mediated familial hypertrophic cardiomyopathy

James O. Mudd, J. Seidman, D. Fatkin, 2000 .

A polymorphic modifier gene alters the hypertrophic response in a murine model of familial hypertrophic cardiomyopathy.

J. Seidman, D. Fatkin, C. Seidman, 2001, Journal of molecular and cellular cardiology.

Single-molecule mechanics of R403Q cardiac myosin isolated from the mouse model of familial hypertrophic cardiomyopathy.

J. Seidman, C. Seidman, M. Tyska, 2000, Circulation research.

The L-type calcium channel inhibitor diltiazem prevents cardiomyopathy in a mouse model.

J. Schmitt, D. Kass, J. Seidman, 2002, The Journal of clinical investigation.

Comparison of Two Murine Models of Familial Hypertrophic Cardiomyopathy

F J Schoen, James O. Mudd, D. Kass, 2001, Circulation research.

The L-type calcium channel inhibitor diltiazem prevents cardiomyopathy in a mouse model

J. Schmitt, D. Kass, J. Seidman, 2002 .

The pathogenesis of familial hypertrophic cardiomyopathy: Early and evolving effects from an α-cardiac myosin heavy chain missense mutation

Dimitrios Georgakopoulos, David A. Kass, D. Kass, 1999, Nature Medicine.